10835 ROAD TO THE CURE, SUITE 140, SAN DIEGO, CA
Reports First Quarter 2026 Business Updates and Financial Results
Annual Report to Security Holders
Other Events
Material disclosure
Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Announces Pricing of Upsized Public Offering of Common Stock
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Amended Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload